This activation subsequently increased BAX expression while reducing the expression of Bcl-2, cyclin-D1, c-myc, and NLRP3, promoting CRC cell cycle arrest, inducing apoptosis, and alleviating inflammation [124]. Here, NLRP3 is linked to colorectal carcinoma.